REG - Smith & Nephew Plc - Director/PDMR Shareholding

Smith & NephewAnnouncement

30/08/2024 10:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240830:nRSd3327Ca&default-theme=true

RNS Number : 3327C  Smith & Nephew Plc  30 August 2024

SMITH & NEPHEW PLC

 

30 August 2024

 

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE
MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.

 

 Reason for the notification
 Initial notification /Amendment                              Initial notification
 Details of the issuer, emission allowance market participant, auction
 platform, auctioneer or auction monitor
 Name                                                         Smith & Nephew plc
 LEI                                                          213800ZTMDN8S67S1H61
 Details of the transaction(s): section to be repeated for (i) each type of
 instrument; (ii) each type of transaction; (iii) each date; and (iv) each
 place where transactions have been conducted
 Description of the financial instrument, type of instrument  Smith & Nephew plc ordinary shares of USD 0.20 each
 Identification code                                          ISIN: GB0009223206
 Nature of the transaction                                    Sale of ordinary shares.
 Date of Transaction                                          2024 - 08 - 29
 Place of Transaction                                         London Stock Exchange (XLON)

 

 Name (Position)              Director / PDMR  Price (£)   Volume        Aggregated information
 Alison Parkes                PDMR             11.760055   3,878 shares  N/A Single Transaction

 (Chief Compliance Officer)

 

 

Helen Barraclough

Company Secretary

Smith & Nephew plc

Tel:  +44 (0)1923 477100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHFIFVATDIIVIS